Clinical trial Recruiting at 2 sites Interventional Ages 15 to 39

Improving a smartphone toolkit to help adolescent and young adult cancer survivors manage depression

Official title: R00 Full Factorial Trial: Optimizing ASCENT

Run by East Carolina University · NCT07173205 · Data updated 2026-11-12

This project will test parts of a digital toolkit to see which pieces help adolescent and young adult cancer survivors reduce symptoms of depression.

More Depression trials

Quick facts

Study typeInterventional
Ages15 Years to 39 Years
SexAll
Enrollment208 (estimated)
SponsorEast Carolina University
Academic / other
Locations2 sites (Greenville, North Carolina and 1 other locations)
StatusRecruiting
StartedOctober 25, 2025
Main results expectedDecember 2026
Study endsMarch 2027
Registry record updatedJanuary 7, 2026
Trial IDNCT07173205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adolescent and young adult cancer survivors aged 15–39 who were diagnosed during adolescence or young adulthood, completed treatment 1 month to 5 years ago, and own a smartphone with a data plan.

Probably not a fit

Patients with severe or persistent mental illness, those with severe suicidal ideation (plan and intent), non-English speakers, or those without a smartphone or outside the eligible post-treatment window are unlikely to benefit from this digital optimization.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will enroll adolescent and young adult (AYA) cancer survivors who are 15–39 years old and finished treatment 1 month to 5 years ago to use a digital intervention called the ASCENT toolkit. The toolkit includes a psychoeducation module plus four evidence-based therapeutic components, and the trial will systematically test individual components and combinations to determine which drive improvements in depressive symptoms. Participants will use the intervention on their smartphones and complete standardized self-report measures of mood over the study period. Investigators will analyze which components or combinations produce the largest, clinically meaningful reductions in depressive symptoms among AYAs.

Why it matters

Potential benefit: If successful, this could produce a personalized, smartphone-based toolkit that reduces depressive symptoms and improves coping for AYA cancer survivors.

How similar studies have gone: Digital interventions and evidence-based components for depression have shown benefit in prior trials, but optimizing which components work best specifically for AYA cancer survivors is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age at enrollment (adolescents 15-17, emerging adults 18-25, young adults 26-39)
* Age at diagnosis (adolescents 12-17, emerging adults 15-25, young adults 15-39)
* Time since completion of treatment: 1 month to 5 years
* Language: Fluent in English (spoken and written)
* Technology: Own smart phone with data plan

Exclusion Criteria:

* Mental Health: Current diagnosis of severe or persistent mental illness
* Suicidality: Severe suicidal ideation (including plan and intent)

Where it's running

  • East Carolina University
    Greenville, North Carolina, United States
    Recruiting
  • Wake Forest University
    Winston-Salem, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Karly M Murphy, PhD — East Carolina University
  • Study coordinator: AnneMarie Coffey, BS
  • Email: coffeya23@ecu.edu
  • Phone: 252-328-6244

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.